Skip to Content

NPM1+CEBPA (SDL12045)

https://www.scanlabglobal.com/web/image/product.template/6730/image_1920?unique=18393fc
Tests NPM1/CEBPA mutations in AML for prognosis. Favorable mutations guide standard chemotherapy, avoiding transplant in AML.

1,900.00 AED 1900.0 AED 1,900.00 AED

1,900.00 AED

Not Available For Sale

This combination does not exist.